|1.||Uckun, Fatih M: 6 articles (04/2012 - 11/2002)|
|2.||D'Cruz, Osmond J: 3 articles (02/2008 - 12/2003)|
|3.||Qazi, Sanjive: 2 articles (04/2012 - 11/2002)|
|4.||Tibbles, Heather E: 2 articles (06/2004 - 01/2004)|
|5.||Vassilev, Alexei O: 2 articles (06/2004 - 01/2004)|
|6.||Petkevich, Alexander S: 2 articles (06/2004 - 01/2004)|
|7.||Titov, Leonid: 2 articles (06/2004 - 01/2004)|
|8.||Waurzyniak, Barbara: 2 articles (12/2003 - 11/2002)|
|9.||D'Cruz, Osmond: 1 article (04/2012)|
|10.||Cahn, Pedro: 1 article (04/2012)|
|1.||HIV Infections (HIV Infection)
|3.||Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever)
06/01/2004 - "Correction: Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus."
01/13/2004 - "Therefore, stampidine shows clinical potential as a new agent for treatment of viral hemorrhagic fevers caused by Lassa virus."
01/13/2004 - "Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus."
|4.||Acquired Immunodeficiency Syndrome (AIDS)
04/01/2012 - "The discovery of stampidine as a potent antiretroviral agent represents a significant step forward in the development of effective therapeutic as well as preventive strategies against HIV/AIDS."
04/01/2012 - "Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS."
11/01/2002 - "We have evaluated the clinical potential of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate(stampidine [STAMP]), a novel aryl phosphate derivative of stavudine, as a new anti-human immunodeficiency virus (anti-HIV) agent, by examining its acute, subacute, and chronic toxicity profile in mice as well as by testing its antiviral activity in a surrogate human peripheral blood lymphocyte (Hu-PBL)-SCID mouse model of human AIDS. "
12/01/2003 - "Stampidine did not cause mucosal inflammation. "